118 related articles for article (PubMed ID: 19002696)
1. Carbon dioxide does not affect the methylation status of prognostic important oncogenes Rassf1A and DCR2 in neuroblastoma cells.
Reismann M; Lehmann D; Quandte M; Ure BM; Glüer S
Pediatr Surg Int; 2008 Dec; 24(12):1327-30. PubMed ID: 19002696
[TBL] [Abstract][Full Text] [Related]
2. Association of RASSF1A, DCR2, and CASP8 Methylation with Survival in Neuroblastoma: A Pooled Analysis Using Reconstructed Individual Patient Data.
Hassan WM; Bakry MS; Siepmann T; Illigens B
Biomed Res Int; 2020; 2020():7390473. PubMed ID: 33381579
[TBL] [Abstract][Full Text] [Related]
3. Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors.
Michalowski MB; de Fraipont F; Plantaz D; Michelland S; Combaret V; Favrot MC
Pediatr Blood Cancer; 2008 Jan; 50(1):29-32. PubMed ID: 17570703
[TBL] [Abstract][Full Text] [Related]
4. Circulating methylated-DCR2 gene in serum as an indicator of prognosis and therapeutic efficacy in patients with MYCN nonamplified neuroblastoma.
Yagyu S; Gotoh T; Iehara T; Miyachi M; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tamura S; Tsuchiya K; Imamura T; Misawa-Furihata A; Sugimoto T; Sawada T; Hosoi H
Clin Cancer Res; 2008 Nov; 14(21):7011-9. PubMed ID: 18980997
[TBL] [Abstract][Full Text] [Related]
5. RASSF1A methylation may have two biological roles in neuroblastoma tumorigenesis depending on the ploidy status and age of patients.
Haruta M; Kamijo T; Nakagawara A; Kaneko Y
Cancer Lett; 2014 Jun; 348(1-2):167-76. PubMed ID: 24680815
[TBL] [Abstract][Full Text] [Related]
6. Carbon dioxide, hypoxia and low pH lead to overexpression of c-myc and HMGB-1 oncogenes in neuroblastoma cells.
Reismann M; Wehrmann F; Schukfeh N; Kuebler JF; Ure B; Glüer S
Eur J Pediatr Surg; 2009 Aug; 19(4):224-7. PubMed ID: 19387923
[TBL] [Abstract][Full Text] [Related]
7. Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome.
Yang Q; Kiernan CM; Tian Y; Salwen HR; Chlenski A; Brumback BA; London WB; Cohn SL
Clin Cancer Res; 2007 Jun; 13(11):3191-7. PubMed ID: 17545522
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation.
van Noesel MM; van Bezouw S; Salomons GS; Voûte PA; Pieters R; Baylin SB; Herman JG; Versteeg R
Cancer Res; 2002 Apr; 62(7):2157-61. PubMed ID: 11929838
[TBL] [Abstract][Full Text] [Related]
9. Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.
Yang Q; Zage P; Kagan D; Tian Y; Seshadri R; Salwen HR; Liu S; Chlenski A; Cohn SL
Clin Cancer Res; 2004 Dec; 10(24):8493-500. PubMed ID: 15623630
[TBL] [Abstract][Full Text] [Related]
10. Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors.
Banelli B; Gelvi I; Di Vinci A; Scaruffi P; Casciano I; Allemanni G; Bonassi S; Tonini GP; Romani M
Oncogene; 2005 Aug; 24(36):5619-28. PubMed ID: 16044164
[TBL] [Abstract][Full Text] [Related]
11. RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker.
Misawa A; Tanaka S; Yagyu S; Tsuchiya K; Iehara T; Sugimoto T; Hosoi H
Br J Cancer; 2009 Jan; 100(2):399-404. PubMed ID: 19165202
[TBL] [Abstract][Full Text] [Related]
12. Exposure to carbon dioxide and helium reduces in vitro proliferation of pediatric tumor cells.
Schmidt AI; Reismann M; Kübler JF; Vieten G; Bangen C; Shimotakahara A; Glüer S; Nustede R; Ure BM
Pediatr Surg Int; 2006 Jan; 22(1):72-7. PubMed ID: 16283335
[TBL] [Abstract][Full Text] [Related]
13. Clustering of hypermethylated genes in neuroblastoma.
van Noesel MM; van Bezouw S; Voûte PA; Herman JG; Pieters R; Versteeg R
Genes Chromosomes Cancer; 2003 Nov; 38(3):226-33. PubMed ID: 14506696
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types.
Shivapurkar N; Toyooka S; Toyooka KO; Reddy J; Miyajima K; Suzuki M; Shigematsu H; Takahashi T; Parikh G; Pass HI; Chaudhary PM; Gazdar AF
Int J Cancer; 2004 May; 109(5):786-92. PubMed ID: 14999791
[TBL] [Abstract][Full Text] [Related]
15. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
[TBL] [Abstract][Full Text] [Related]
16. CO2 Pneumoperitoneum Effects on Molecular Markers of Tumor Invasiveness in SH-SY5Y Neuroblastoma Cells.
Montalto AS; Currò M; Russo T; Ferlazzo N; Caccamo D; Ientile R; Romeo C; Impellizzeri P
Eur J Pediatr Surg; 2020 Dec; 30(6):524-528. PubMed ID: 31707727
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic alterations in sporadic basal cell carcinomas.
Stamatelli A; Vlachou C; Aroni K; Papassideri I; Patsouris E; Saetta AA
Arch Dermatol Res; 2014 Aug; 306(6):561-9. PubMed ID: 24573469
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521
[TBL] [Abstract][Full Text] [Related]
19. Association of aberrant DNA methylation with clinicopathological features in breast cancer.
Tserga A; Michalopoulos NV; Levidou G; Korkolopoulou P; Zografos G; Patsouris E; Saetta AA
Oncol Rep; 2012 May; 27(5):1630-8. PubMed ID: 22159596
[TBL] [Abstract][Full Text] [Related]
20. Re-expression of RASSF1A by 5-Aza-CdR induced demethylation of the promoter region in human biliary tract carcinoma cells.
Zuo S; Chen Y; Xu L; Tang Q; Zou S
J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):281-4. PubMed ID: 17641842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
